SM

Sunil Mehta

Active Director Director DIN 07547545
DIN 07547545 First appointment Aug 2016 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2016
Shareholding value •••• Premium profile

About Sunil Mehta

Data last updated:

Sunil Mehta is a Director at Villsun Laboratories (India) Limited (since 2016). The company operates in Pharma. Villsun Laboratories (India) Limited reported revenue of ₹1.94 Cr (FY 2024).

DIN 07547545
Primary Designation Director
Industry Pharma
First Appointment 22 Aug 2016
Oldest Company Age 10 yrs
Largest company Villsun Laboratories (India) Limited · ₹1.94 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Villsun Laboratories (India) Limited U24290MP2016PLC041355
Director22 Aug 20162016₹1.94 Cr (FY 2024)Active

Board colleagues of Sunil Mehta

Directorship timeline

Open interactive timeline →
Villsun Laboratories (India) Limited
Premium access

Shareholding and investment profile for Sunil Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunil Mehta

Sunil Mehta currently holds 1 directorship: Villsun Laboratories (India) Limited (Director, since 22 Aug 2016, revenue ₹1.94 Cr (FY 2024)).

Sunil Mehta was first appointed on 22 Aug 2016 as Director at Villsun Laboratories (India) Limited.

The current boards of Sunil Mehta's companies include Pramila Sharma (Villsun Laboratories (India) Limited), Vinay Sharma Kumar (Villsun Laboratories (India) Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available